A detailed history of Ifg Advisory, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Ifg Advisory, LLC holds 6,110 shares of BSX stock, worth $627,435. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,110
Previous 7,986 23.49%
Holding current value
$627,435
Previous $857,000 30.46%
% of portfolio
0.03%
Previous 0.04%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

SELL
$97.03 - $108.14 $182,028 - $202,870
-1,876 Reduced 23.49%
6,110 $596,000
Q2 2025

Aug 04, 2025

BUY
$89.7 - $107.41 $7,803 - $9,344
87 Added 1.1%
7,986 $857,000
Q1 2025

May 08, 2025

BUY
$89.38 - $106.18 $40,042 - $47,568
448 Added 6.01%
7,899 $796,000
Q4 2024

Feb 14, 2025

BUY
$83.62 - $91.5 $623,052 - $681,766
7,451 New
7,451 $665,000
Q2 2024

Jul 30, 2024

BUY
$67.33 - $77.71 $361,090 - $416,758
5,363 New
5,363 $413,000
Q1 2023

Apr 26, 2023

BUY
$45.09 - $50.03 $204,212 - $226,585
4,529 New
4,529 $226,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $147B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Ifg Advisory, LLC Portfolio

Follow Ifg Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifg Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ifg Advisory, LLC with notifications on news.